UPCC 06024 A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Haploidentical Related, Partially HLA-Mismatched, or Matched Unrelated Bone Marrow for Newly Diagnosed Patients with Severe Aplastic Anemia (BMT-CTN 2207)
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
This study is a prospective, multicenter Phase II study with participants receiving haploidentical transplantation or unrelated donor transplantation for previously untreated severe aplastic anemia (SAA).
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
13 Nov 2024.
Study ID: 856824
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
